International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
South American Institute of Government in Health South American Institute of Government in Health The South American Institute of Government in Health (ISAGS) is a public intergovernamental institution of UNASUR whose main goal is to promote exchange, critical thinking, knowledge management and generate innovation in policy and governance for health, thus offering South American Health Ministries the best available practices and evidences on health management. It was created by the Heads of State and Government of UNASUR after a proposal of the South American Council of Health gathered in Cuenca, Ecuador, in April 2010. According to the institute's Executive Director José Gomes Temporão, "Isags works in alliance